Internationally renowned investigator Dr. Michael Jacobs and his colleagues have published a detailed summary of their research spanning 18 years studying the bacterial contamination and septic reaction rates associated with platelet transfusion both before and after the introduction of primary culture. They compare in detail their rates to other published studies. These distinguished investigators offer cogent conclusions and recommendations for mitigation of this serious, potentially fatal risk.
The Company's first product is the Platelet PGD Test – a rapid test for the detection of bacterial contamination in platelets.